http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016198075-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6179cf110b5edb71a7efccb24b081fe |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-12 |
filingDate | 2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4f81c1d059812ad42783e9312e4bf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_884d346e438723550d02a964a068dedc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f30dd2fc972f1ea1a16d3e79103107 |
publicationDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2016198075-A |
titleOfInvention | Enzyme production of cytosine nucleoside analogues |
abstract | Cytosine nucleoside analogs, intermediates, or prodrugs thereof shorten conventional multi-step synthesis, increase overall yield, reduce side reactions and by-product content, and thus improve product purity and quality By providing improved and alternative synthetic methods for nucleoside analogs useful as anti-cancer and / or anti-viral products. A method of synthesizing cytosine nucleoside analogs using nucleoside phosphorylase enzymes, particularly pyrimidine nucleoside phosphorylases (PyNPs), or a mixture of purine nucleoside phosphorylases (PNPs) and PyNPs. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109651467-A |
priorityDate | 2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 776.